JBC PeproTech; Our Business is Cytokines!

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M107129200 on October 15, 2001

J. Biol. Chem., Vol. 276, Issue 51, 48518-48525, December 21, 2001
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/51/48518    most recent
M107129200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jian, X.
Right arrow Articles by Northup, J. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jian, X.
Right arrow Articles by Northup, J. K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Gbeta gamma Affinity for Bovine Rhodopsin Is Determined by the Carboxyl-terminal Sequences of the gamma  Subunit*

Xiaoying JianDagger §, William A. ClarkDagger §, Jeffrey Kowalak||, Sanford P. Markey||, William F. Simonds**, and John K. NorthupDagger DaggerDagger

From the Dagger  Laboratory of Cellular Biology, NIDCD, the || Laboratory of Neurotoxicology, National Institute of Mental Health, and the ** Metabolic Diseases Branch, NIDDK, National Institutes of Health, Bethesda, Maryland 20892

Received for publication, July 27, 2001, and in revised form, October 12, 2001


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Two native beta gamma dimers, beta 1gamma 1 and beta 1gamma 2, display very different affinities for receptors. Since these gamma  subunits differ in both primary structure and isoprenoid modification, we examined the relative contributions of each to Gbeta gamma interaction with receptors. We constructed baculoviruses encoding gamma 1 and gamma 2 subunits with altered CAAX (where A is an aliphatic amino acid) motifs to direct alternate or no prenylation of the gamma  chains and a set of gamma 1 and gamma 2 chimeras with the gamma 2 CAAX motif at the carboxyl terminus. All the gamma  constructs coexpressed with beta 1 in Sf9 cells yielded beta 1gamma dimers, which were purified to near homogeneity, and their affinities for receptors and Galpha were quantitatively determined. Whereas alteration of the isoprenoid of gamma 1 from farnesyl to geranylgeranyl and of gamma 2 from geranylgeranyl to farnesyl had no impact on the affinities of beta 1gamma dimers for Galpha t, the non-prenylated beta 1gamma 2 dimer had significantly diminished affinity. Altered prenylation resulted in a <2-fold decrease in affinity of the beta 1gamma 2 dimer for rhodopsin and a <3-fold change for the beta 1gamma 1 dimer. In each case with identical isoprenylation, the beta 1gamma 2 dimer displayed significantly greater affinity for rhodopsin compared with the beta 1gamma 1 dimer. Furthermore, dimers containing chimeric Ggamma chains with identical geranylgeranyl modification displayed rhodopsin affinities largely determined by the carboxyl-terminal one-third of the protein. These results indicate that isoprenoid modification of the Ggamma subunit is essential for binding to both Galpha and receptors. The isoprenoid type influences the binding affinity for receptors, but not for Galpha . Finally, the primary structure of the Ggamma subunit provides a major contribution to receptor binding of Gbeta gamma , with the carboxyl-terminal sequence conferring receptor selectivity.


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Heterotrimeric G proteins1 transduce a wide variety of extracellular signals recognized by seven-transmembrane receptors, initiating signaling through a diverse array of intracellular effectors (1). G proteins are composed of three polypeptides: a GTP-binding alpha  subunit and a dimer of beta  and gamma  subunits that functions as a monomer. Ligand-activated G protein-coupled receptors catalyze the exchange of GTP for GDP tightly bound to the inactive Galpha subunit, resulting in dissociation of the GTP-activated alpha  subunit from both its cognate Gbeta gamma dimer and the receptor. The GTP-activated alpha  subunit and the dissociated Gbeta gamma dimer in turn regulate intracellular effectors (1, 2). At least 20 different alpha  subunits, 5 beta  subunits, and 12 gamma  subunits (3) have been identified to date. Such a diversity of structures is believed to contribute importantly to the specificity of signaling through these pathways.

It is well established that the selective interaction between receptors and the Galpha subunits provides a major determinant of signaling specificity. There are numerous examples of the selectivity of receptors for Galpha subunits. For example, the beta -adrenergic receptor couples primarily to members of the Galpha s family (4-6), whereas the alpha 2A-adrenergic receptor couples to members of the Galpha i family (7-10). G protein-coupled receptors can even display remarkable selectivity among closely related Galpha structures. The bombesin receptor subtypes selectively couple with different subtypes of Galpha q (11). A growing body of evidence also points to the contribution of beta gamma subunits in determining receptor-G protein coupling selectivity. The role of beta gamma diversity in the specificity of G protein signaling is supported by both in vivo and in vitro studies. Antisense RNA constructs for Galpha , Gbeta , and Ggamma selectively disrupt receptor signaling in rat pituitary GH3 cells (12, 13). These studies have demonstrated a specific requirement of beta 3 and gamma 4 subunits for muscarinic receptor signaling, whereas beta 1 and gamma 3 subunits mediate somatostatin receptor signaling. Also, ribozyme-mediated suppression of gamma 7 subunit expression has led to a specific attenuation of beta -adrenergic receptor signaling in HEK293 cells (14). Moreover, in vitro reconstitution with dimers of differing beta gamma composition demonstrates that both the beta  subunit (15-17) and the gamma  subunit (16, 18, 19) provide coupling specificity for various receptors. We initially interpreted the synergy and beta gamma selectivity of rhodopsin-catalyzed GTP binding to Galpha t to mean that rhodopsin made independent binding contacts with the alpha  and beta gamma subunits (20). Direct interaction of transducin beta gamma with rhodopsin has been demonstrated separately with fluorescence spectroscopy (21) and with surface plasmon resonance measurements (22). A receptor contact site on the beta  subunit was identified in cross-linking studies in which a synthetic peptide derived from the third intracellular loop of the alpha 2A-adrenergic receptor could be cross-linked to the carboxyl-terminal region of the beta  subunit (23).

A series of post-translational modifications are required for the functions of G proteins. In the case of Ggamma subunits, these modifications include the thioether linkage of an isoprenoid group to the conserved cysteine side chain within a carboxyl-terminal CAAX motif (where C is cysteine, A is an aliphatic amino acid, and X is any amino acid), proteolytic cleavage of the AAX tripeptide, and methylation of the resulting carboxyl terminus. The terminating residue in the CAAX motif appears to determine the identity of the isoprenoid. G protein subunits gamma 1, gamma 8 (cone) and gamma 11 with serine at this position are modified with a 15-carbon farnesyl, whereas the other gamma  subunits terminating in leucine are modified with a 20-carbon geranylgeranyl. The lipid modification of the gamma  subunits has been shown to be responsible for attaching G proteins to membranes (24, 25). There is also ample evidence suggesting the involvement of the prenyl groups in protein-protein interactions (26-29). Two beta gamma dimers, beta 1gamma 1 and beta 1gamma 2, display a >10-fold difference in their affinity for bovine rhodopsin (20, 30), but no apparent difference in interaction with retinal Galpha t. Since these two gamma  subunits differ in both primary amino acid sequence and isoprenoid modification, we designed this study to examine the quantitative contributions of isoprenoid modification and protein structure to the beta gamma dimer affinity for rhodopsin. Our data indicate that although the lipid modification is essential for a competent beta gamma dimer, the type of prenyl group on the gamma  subunits influences the binding affinity for rhodopsin, but not for Galpha t. In addition, the primary structure of the gamma  subunit provides a major contribution to rhodopsin binding of beta gamma dimers, with the carboxyl-terminal sequences conferring receptor selectivity.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Construction of gamma  Prenylation Mutants and Chimeras-- Mutant and chimeric gamma  cDNA clones were made by PCR amplification. Bovine gamma 1 and gamma 2 were the original templates. A recombinant baculovirus encoding gamma 1-CVIL (31) was kindly provided by Dr. James Garrison (University of Virginia), and recombinant baculoviruses encoding gamma 2-CVIS and the cysteine-terminated construct "gamma 2-A" were gifts from Dr. Nick Ryba (NIDCR, National Institutes of Health). Plasmids encoding chimeric gamma 1/gamma 2 structures as previously reported (32) were used as PCR templates for generating the current chimeric gamma  cDNA constructs, in which all the 3'-reverse primers contained nucleotides encoding CAIL prior to the stop codon. The resulting chimeric gamma  structures therefore all contain a carboxyl-terminal sequence that is known to direct geranylgeranylation. The PCR products encoding the chimeric gamma  structures were cloned into the transfer vector pBacPAK8 (CLONTECH) for production of recombinant baculoviruses. Insect cell culture, transfection, plaque purification, and virus amplification were carried out according to the manufacturer's recommended procedures (CLONTECH).

Purification of G Protein Subunits-- G proteins were isolated from bovine retina and baculovirus-infected Sf9 cells expressing recombinant beta 1gamma dimers. Bovine retinal transducin was isolated from rod outer segment discs prepared by discontinuous gradient sedimentation (33). Galpha t and beta 1gamma 1 were purified using previously published procedures (20, 34, 35). Sf9 cell-expressed beta 1gamma dimers were purified as described for beta 1gamma 2 (30) with minor modifications. Sf9 cells were co-infected with beta 1-encoding and the appropriate gamma -encoding baculoviruses at multiplicities of infection of 1 for the beta 1 virus and 3 for the gamma  virus. The cells were harvested 60 h after infection; the cells were lysed; and a P2 membrane fraction was isolated. All the dimers were purified from Sf9 cell membranes, except beta 1gamma 2-A, which was purified from the cytosolic fraction. After sequential chromatography over DEAE-Sephacel (Amersham Pharmacia Biotech) and Ultrogel AcA44 (IBF), the fractions containing the beta 1gamma dimers were pooled and concentrated and then further purified on a Superdex HR-75 FPLC column (Amersham Pharmacia Biotech) with the final storage solution (10 mM MOPS, pH 7.5, 100 mM NaCl, and 8 mM CHAPS). Two of the samples, beta 1gamma 221 and beta 1gamma 2-A, required an additional step of purification through a Mono-Q FPLC column (Amersham Pharmacia Biotech) before the final Superdex HR-75 FPLC size-exclusion chromatography.

Electrophoretic Methods-- Pre-cast Tricine-16% acrylamide gels (Novex) were run according to the manufacturer's protocol. Samples were electrophoresed at 125 V for ~90 min at room temperature. Protein bands were visualized by Coomassie Blue staining.

Mass Spectrometry-- Liquid chromatography/mass spectrometry was performed by directly coupling a Shimadzu LC10VP HPLC system to the electrospray ion source of an LCQ ion trap mass spectrometer. Reversed-phase HPLC was performed at a flow rate of 10 µl/min using a 0.3 × 100-mm Betabasic 4 column (Keystone Scientific Inc., Bellefonte, PA). Solution A was H2O/acetonitrile (19:1) and 0.1% formic acid; Solution B was acetonitrile/1-propanol (4:1) and 0.1% formic acid. The column was equilibrated at 80% Solution A and 20% Solution B, and the chromatograph was developed using a linear gradient to 20% Solution A and 80% Solution B in 20 min. Full scan mass spectra over the m/z 300-2000 range were acquired continuously for the duration of the chromatography.

beta gamma dimers were prepared for mass spectrometry by acetone precipitation. Samples (60-201 pmol in 20 µl) in 8 mM CHAPS were mixed with 9 volumes of ice-cold acetone in a Vortex mixer and incubated for 20 min on ice, and precipitates were collected by sedimentation at 12,000 × g for 15 min at 4 °C. After aspirating the supernatant liquid, pellets were allowed to air-dry and then were suspended in 25 µl of Solution A, and 5 µl of the sample was injected for liquid chromatography/mass spectrometry analysis.

Protein Concentration Determination-- Galpha t concentration was determined by rhodopsin-catalyzed GTPgamma S binding (20). Gbeta 1gamma 1 was determined by the Amido Black binding assay (36) using bovine serum albumin as a standard. The protein concentrations of all other beta 1gamma dimers were determined from the staining intensity of the beta  chain calibrated with different amounts of beta 1gamma 1 on a Coomassie Blue-stained gel by densitometry, with all the samples and beta 1gamma 1 standards within linear range.

Reconstitution Assays-- The activities of the beta 1gamma dimers were quantified by rhodopsin-catalyzed GTPgamma S binding to Galpha t and pertussis toxin-catalyzed ADP-ribosylation of Galpha t as described previously (20). For both assays, the detergent CHAPS was adjusted to a final concentration of 1.6 mM. Urea-washed rod outer segment disc membranes, the source of rhodopsin, were prepared as described (37). Initial rate estimates for the catalyzed GTPgamma S binding to Galpha t and pertussis toxin-catalyzed ADP-ribosylation of Galpha t were determined by single time point reactions, which consumed <20% of the Galpha t substrate.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The goal of this study was to delineate the relative contributions of isoprenoid modification and protein structure of the Ggamma subunit to the interactions of the beta gamma dimer with Galpha subunits and receptors. We have examined these questions using the retinal G protein and rhodopsin because affinity differences between beta 1gamma 1 and beta 1gamma 2 dimers are well characterized for this receptor, and these two dimers differ in both the primary structure and isoprenoid modification of the gamma  chain. Data from several laboratories have suggested that the isoprenoid modification provides the major determinant of differences between these two dimers, so we initially tested the effects of altering the prenylation. To examine this question, we tested three mutant gamma  constructs: the gamma 1 mutant gamma 1-CVIL was expected to change gamma 1 from farnesyl to geranylgeranyl; the gamma 2 mutant gamma 2-CVIS was expected to change gamma 2 from geranylgeranyl to farnesyl; and gamma 2-A, a truncated form of gamma 2 that terminates at the cysteine residue of the CAAX motif, was expected to result in a mature protein lacking any prenyl group. Co-infection of Sf9 cells with viruses encoding these mutant gamma  constructs and a beta 1-encoding virus resulted in the expression of a beta 1gamma dimer for all constructs. Fig. 1 shows the beta 1gamma dimers resulting from such co-infections purified to near homogeneity and separated on a Tricine gel stained with Coomassie Blue. The electrophoretic mobility differences among the gamma  chains are noticeable in this gel system. None of the samples contained any detectable Galpha contamination measured in the rhodopsin-catalyzed GTPgamma S exchange assay or pertussis toxin-catalyzed ADP-ribosylation assay (data not shown).


View larger version (69K):
[in this window]
[in a new window]
 
Fig. 1.   SDS-PAGE of purified Gbeta 1gamma subunits with altered isoprenylation. Purified recombinant beta gamma subunits of defined subtypes were electrophoresed on a Tricine-16% acrylamide gel and stained with Coomassie Blue. The positions of the beta 1 and various gamma  subunits are indicated on the left.

To confirm the nature of the post-translational modifications, we analyzed purified beta 1gamma dimers using electrospray ionization mass spectrometry. Fig. 2 shows the deconvoluted mass spectra of gamma 1, gamma 1-CVIL, gamma 2, and gamma 2-CVIS. The observed molecular mass for each of the gamma  constructs is summarized in Table I. As predicted, the gamma 1 subunit showed a molecular mass of 8332 Da, in agreement with the calculated molecular mass of the polypeptide chain deduced from the DNA sequence plus all known post-translational modifications. They include removal of the amino-terminal methionine, attachment of a farnesyl group to cysteine 71, removal of the carboxyl-terminal tripeptide, and methylation of the new carboxyl terminus. The gamma 1-CVIL sequence is predicted to direct geranylgeranyl modification. The observed mass of 8401 Da is consistent with exchange of the farnesyl group of wild-type gamma 1 for a geranylgeranyl. Consistent with the findings of Lindorfer et al. (31), the mass spectra also showed a set of signals corresponding to the fully processed molecule minus the prenyl group. These authors have demonstrated that the loss of the farnesyl group occurs during the ionization process and is not due to heterogeneity of modification. Our data are consistent with their findings since the HPLC elution resolves gamma 1 chains bearing differing isoprenoid modification prior to the ionization for the mass spectrometry. The gamma 2 and gamma 2-CVIS subunits also showed the observed masses consistent with the amino acid composition deduced from the DNA sequence plus the predicted isoprenoid modifications (farnesyl for gamma 2-CVIS and geranylgeranyl for gamma 2), endoproteolysis, carboxyl methylation, the removal of the amino-terminal methionine, and amino-terminal acetylation. The gamma 2-A chain showed an observed mass of 7463 Da, consistent with that of the predicted amino acid sequence of gamma 2 terminating at cysteine of the CAIL carboxyl terminus, lacking prenylation or methylation, with its amino-terminal methionine removed and the new amino terminus acetylated. Minor amounts of inappropriately prenylated species were observed for the gamma 2 products (Fig. 2, C and D). The relative abundance of farnesylated versus geranylgeranylated gamma  subunits is summarized in Table I as well.


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 2.   Electrospray ionization mass spectra of recombinant beta 1gamma subunits with altered isoprenylation. Samples of purified dimers containing prenylation mutant and wild-type gamma  chains were acetone-precipitated and analyzed by liquid chromatography/mass spectrometry as described under "Experimental Procedures." The sample amounts were as follows: retinal beta 1gamma 1, 40 pmol; beta 1gamma 1-CVIL, 40 pmol; wild-type beta 1gamma 2, 19 pmol; beta 1gamma 2-CVIS, 40 pmol. The spectra are labeled for the masses corresponding to gamma  chains modified with farnesyl (C15) and geranylgeranyl (C20) or non-prenylated with and without methyl (CH3).

                              
View this table:
[in this window]
[in a new window]
 
Table I
Molecular masses of gamma  subunits with altered isoprenylation sequences

To assess the effects of altering prenylation of Ggamma on beta gamma interactions with receptors, we tested beta gamma -dependent, rhodopsin-catalyzed GTPgamma S binding to Galpha t in the presence of different beta 1gamma samples. Fig. 3 shows results from one such experiment. The K1/2 values obtained are summarized in Table II. The beta 1gamma 1 subunit showed a >12-fold lower affinity compared with the beta 1gamma 2 subunit for rhodopsin (K1/2 = 227 versus 18 nM). When gamma 1 prenylation was altered from farnesyl to geranylgeranyl, the affinity of beta 1gamma 1-CVIL for rhodopsin increased almost 3-fold (Fig. 3A), but still did not equal that of beta 1gamma 2 for rhodopsin (K1/2 = 78 versus 18 nM). When gamma 2 prenylation was altered from geranylgeranyl to farnesyl, the affinity of beta 1gamma 2-CVIS for rhodopsin decreased <2-fold (Fig. 3B), distinct from the lower affinity of beta 1gamma 1 for rhodopsin (K1/2 = 31 versus 227 nM). However, although the alteration of gamma 2 prenylation from geranylgeranyl to farnesyl diminished affinity for rhodopsin only modestly, the absence of a prenyl group diminished the interaction of the beta 1gamma 2-A dimer to undetectable levels, with no enhancement of GTPgamma S binding at all (Fig. 3A). These data suggest an absolute requirement for the isoprenoid modification of the gamma  subunit for the beta gamma interaction with receptors.


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 3.   Saturation of rhodopsin-catalyzed GTPgamma S binding to Galpha t by beta 1gamma subunits with altered isoprenylation. The indicated concentrations of beta 1gamma 1 (black-square), beta 1gamma 1-CVIL (black-triangle), and beta 1gamma 2-A () in A and beta 1gamma 2 (black-down-triangle ) and beta 1gamma 2-CVIS (black-diamond ) in B were incubated in reactions containing 500 nM Galpha t and 30 nM rhodopsin as described under "Experimental Procedures." The curves drawn are the best fit for a single site binding model using GraphPAD Prism.

                              
View this table:
[in this window]
[in a new window]
 
Table II
Activity assessment of beta 1gamma dimers with altered isoprenylation

To determine whether the differences in affinity observed among beta gamma subunit forms were due to differing affinities for interaction with Galpha t, we analyzed the beta gamma dependence of pertussis toxin-catalyzed ADP-ribosylation of Galpha t. Fig. 4 shows the saturation of ADP-ribosylation of Galpha t by increasing concentrations of different forms of beta 1gamma dimers. In contrast with the rhodopsin-catalyzed GTPgamma S binding to Galpha t, the pertussis toxin-catalyzed ADP-ribosylation of Galpha t displayed no distinction between beta 1gamma 1 and beta 1gamma 2 with either form of prenylation (Table II). The non-prenylated gamma 2 dimer (beta 1gamma 2-A) displayed a measurable enhancement of the ADP-ribosylation of Galpha t, but with an affinity for Galpha t that was >30-fold lower than that for the prenylated beta 1gamma 1 or beta 1gamma 2 dimer. These data suggest that for the beta gamma interaction with the Galpha subunit, the isoprenoid modification of the gamma  subunit, not the exact identity of the prenyl group, is important.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 4.   Saturation of pertussis toxin-catalyzed ADP-ribosylation of Galpha t by beta 1gamma subunits with altered isoprenylation. The indicated concentrations of beta 1gamma 1 (black-square), beta 1gamma 1-CVIL (black-triangle), beta 1gamma 2 (black-down-triangle ), beta 1gamma 2-CVIS (black-diamond ), and beta 1gamma 2-A () were incubated in reactions containing 500 nM Galpha t and 5 µg/ml pertussis toxin as described under "Experimental Procedures." The curves drawn are the best fit for a single site binding model using GraphPAD Prism.

Since the difference in prenyl group did not account for the majority of the affinity difference between beta 1gamma 1 and beta 1gamma 2 for rhodopsin, we investigated the contribution of primary structures. Fig. 5 depicts the set of chimeras we employed containing heterologous sequence at approximately one-third intervals based upon regions of sequence identity between the gamma 1 and gamma 2 proteins. These constructs were based upon the previously published chimeras (32), except that all of the chimeric constructs were altered to code for CAIL at the carboxyl terminus so that they would all have the same geranylgeranyl modification. Co-infection of Sf9 cells with baculoviruses encoding these chimeric gamma  chains and a beta 1-encoding virus led to the expression of beta 1gamma dimers for all constructs. Because the yields of beta 1gamma 111 protein were quite low, we used the beta 1gamma 1-CVIL product for this protein structure. beta 1gamma 222 is the wild-type beta 1gamma 2 construct. Fig. 6 shows the beta 1gamma chimeras along with the parent structure beta 1gamma 1-CVIL and beta 1gamma 2 purified to near homogeneity and separated on a Tricine-16% acrylamide gel stained with Coomassie Blue. As found for the prenylation mutant gamma  chains, this gel system clearly resolves the chimeric gamma  chains. HPLC electrospray ionization mass spectrometry confirmed that the isoprenoid modification of the gamma  chains was predominantly the geranylgeranyl directed by the CAIL sequence. Geranylgeranyl-modified chain accounted for >74% of the mass of each purified gamma  subunit (Table III).


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 5.   Construction of chimeric gamma  subunits. A, the amino acid sequences of the gamma 1 and gamma 2 subunits served as parent structures for the chimeric gamma  subunits as previously described (32). Numbers on the right indicate the amino acid residue positions. Before C-terminal processing, gamma 1 contains 74 residues, and gamma 2 contains 71 residues. In the current constructs, the C-terminal CAAX motif in gamma 1 has been changed from its native CVIS to CAIL so that all the resulting chimeric gamma  subunits contain the same C-terminal CAIL as gamma 2 that directs geranylgeranylation. Boldface residues (QLK and EDPL) correspond to sequence motifs used as junctions between chimeric segments. B, shown is a schematic overview of the gamma 1/gamma 2 chimeras. Open bars indicate polypeptide sequence derived from gamma 1, and closed bars indicate that derived from gamma 2. Vertical lines indicate junctions between chimeric segments.


View larger version (95K):
[in this window]
[in a new window]
 
Fig. 6.   SDS-PAGE of purified Gbeta 1gamma subunits with chimeric gamma  chains. Purified recombinant beta gamma subunits of defined subtypes were electrophoresed on a Tricine-16% acrylamide gel and stained with Coomassie Blue. The positions of the beta 1 and various gamma  subunits are indicated on the left.

                              
View this table:
[in this window]
[in a new window]
 
Table III
Molecular masses of chimeric gamma  subunits

Fig. 7 shows the saturation of rhodopsin-catalyzed GTPgamma S binding to Galpha t for the purified beta 1gamma chimeras. They displayed clear differences in both affinity and maximum catalytic rate, as seen for the dimers containing the parent gamma 1 or gamma 2 protein. These differences could be sorted based upon the identity of the sequence for the carboxyl-terminal one-third of the chimera. As summarized in Table IV, beta 1gamma 122 and beta 1gamma 112 had similar high affinity for rhodopsin compared with beta 1gamma 2 (K1/2 = 24, 23, and 18 nM, respectively). The other two chimeric dimers, beta 1gamma 221 and beta 1gamma 211, had lower apparent affinity (K1/2 = 39 and 68 nM, respectively), with the value for the latter close to the value for beta 1gamma 111 (i.e. beta 1gamma 1-CVIL, 78 nM). This result suggests that the primary structure in the carboxyl-terminal region of the gamma  subunit determines the affinity of the interaction with rhodopsin. The amino acid sequence in the middle and amino-terminal regions of the gamma 2 subunit also contributed to the high affinity interaction, although to a lesser degree.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 7.   Saturation of rhodopsin-catalyzed GTPgamma S binding to Galpha t by beta 1gamma subunits with chimeric gamma  chains. The indicated concentrations of beta 1gamma 122 (black-square), beta 1gamma 112 (black-triangle), beta 1gamma 221 (black-down-triangle ), and beta 1gamma 211 () were incubated in reactions containing 500 nM Galpha t and 30 nM rhodopsin as described under "Experimental Procedures." The curves drawn are the best fit for a single site binding model using GraphPAD Prism.

                              
View this table:
[in this window]
[in a new window]
 
Table IV
Activity assessment of beta 1gamma dimers with chimeric gamma  chains

As expected from the similar affinities of wild-type beta 1gamma 1 and beta 1gamma 2, the beta 1gamma chimeras, beta 1gamma 1-CVIL, and beta 1gamma 2 showed essentially identical affinity for Galpha t in the pertussis toxin-catalyzed ADP-ribosylation assay (Fig. 8 and Table IV). These data imply that the affinity differences found for dimers with distinct gamma  subunit primary structures are due to differences in rhodopsin-beta gamma interaction rather than differences in beta gamma -Galpha t interaction.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 8.   Saturation of pertussis toxin-catalyzed ADP-ribosylation of Galpha t by beta 1gamma subunits with chimeric gamma  chains. The indicated concentrations of beta 1gamma 111 (i.e. beta 1gamma 1-CVIL; ), beta 1gamma 122 (black-square), beta 1gamma 211 (black-triangle), beta 1gamma 112 (black-down-triangle ), beta 1gamma 221 (black-diamond ), and beta 1gamma 222 (i.e. wild-type beta 1gamma 2; open circle ) were incubated in reactions containing 500 nM Galpha t and 5 µg/ml pertussis toxin as described under "Experimental Procedures." The curves drawn are the best fit for a single site binding model using GraphPAD Prism.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

With the emerging evidence suggesting that in addition to the Galpha subunit, both the beta  and gamma  subunits of G proteins also affect receptor-G protein interactions (15-19), it has become an increasingly accepted notion that beta gamma dimers contribute to the selectivity of the receptor interaction. This study examined quantitatively the role of the prenyl modification and amino acid sequence of the Ggamma subunit in determining signaling specificity. We confirmed that the apparent affinity for rhodopsin was >12 times higher for beta 1gamma 2 than for beta 1gamma 1 for the wild-type structures, whereas the two beta 1gamma dimers displayed no difference in affinity for retinal Galpha t. Although one study using rhodopsin to catalyze GDP/GTP exchange on the Galpha t subunit showed that the beta 1gamma 1 dimer supported a faster rate of exchange than did beta 1gamma 2 or beta 1gamma 3 (38), others have found a much lower apparent affinity for beta 1gamma 1 than for other beta gamma dimers (20, 27, 30, 39). The direct measurement of rhodopsin-G protein interactions using surface plasmon resonance also revealed a higher affinity of beta 1gamma 2 for rhodopsin compared with beta 1gamma 1 and showed that this difference was due to a lower dissociation rate for beta 1gamma 2 (22). We have capitalized upon this significant quantitative difference in the binding interaction with rhodopsin to assess the independent contributions of the gamma  subunit primary structure and post-translational modification to this difference. Our results clearly implicate the primary structure of the gamma  chain as a major determinant of the affinity of beta 1gamma dimers for rhodopsin. The set of gamma  chimeras with uniform geranylgeranyl modification further pinpointed the carboxyl-terminal sequence of the gamma  subunit as the region responsible for receptor selectivity. Underscoring the importance of the amino acid sequence of the gamma  subunit in receptor-G protein interactions, a recent study showed that beta 1gamma 1 supported only a very low level of coupling to the alpha 2A-adrenergic receptors, whereas the beta 1gamma 11 dimer produced a high level of coupling (16). Since both the gamma 1 and gamma 11 subtypes are farnesylated, the difference in coupling level observed for these dimers must also be attributed to differences in the amino acid sequences.

Consistent with previous findings on 5-hydroxytryptamine type 1A receptors (40), adenosine receptors (28), and bombesin receptors (11), we found that bovine rhodopsin prefers Galpha beta gamma complexes containing the geranylgeranylated gamma  subunit. Our results obtained with prenylation mutants confirmed the findings of several laboratories that dimers containing geranylgeranylated gamma  subunits have higher affinities for receptors than those with farnesylated gamma  chains (11, 27, 28, 40). In our study, given the same amino acid sequence of the gamma  subunit, the beta 1gamma dimer was more effective in coupling the Galpha t subunit to rhodopsin when the gamma  subunit was modified with geranylgeranyl compared with farnesyl. Furthermore, a prenylation-deficient construct was found to be incompetent to participate in these protein-protein interactions. Although this has suggested that the affinity differences found between retinal beta 1gamma 1 and other beta gamma dimers could be attributed solely to the isoprenylation difference (27, 28), we found that identically isoprenylated beta 1gamma 1 and beta 1gamma 2 retained significant affinity differences for bovine rhodopsin for both geranylgeranylated and farnesylated gamma  chains. Moreover, the effect of the prenyl type was more profound with the gamma 1 primary structure than with the gamma 2 structure, which implies the importance of the amino acid sequence of the gamma 2 subunit in conferring a high affinity rhodopsin interaction.

The apparent affinity differences that we measured for bovine rhodopsin for this set of beta 1gamma dimers with varying gamma  compositions clearly do not originate from distinct Galpha t interaction since all of the dimers displayed essentially identical apparent affinity for Galpha t, as others have also noted for the retinal G protein subunits (20, 41). This may not be the case for beta gamma dimers interacting with other Galpha proteins. A significant difference in apparent affinity for Galpha s, but not for Galpha o or Galpha i, has been reported for beta gamma dimers of differing compositions (42). Whereas ADP-ribosylation by pertussis toxin did not reveal a difference among brain beta gamma dimers for Galpha o, inhibition of GDP release did (41). Since the primary contacts between Galpha and Gbeta gamma occur within the amino-terminal sequences of alpha  subunits, and these are distinct for the various Galpha species, it is likely that alpha  subunit selectivity may contribute importantly to differences among beta gamma dimers in receptor signaling. This will be important to clarify in future studies.

The differences that we observed among the beta gamma dimers in rhodopsin interaction are also not likely to originate from the different purities of the samples. We have previously shown that substances interfering with the quantitative assay of beta gamma dimers in cholate extracts from Y1 adrenal cortical tumor cells were completely removed by chromatography over Ultrogel AcA44 (43). Similarly, we found that chromatography over DEAE-Sephacel was sufficient to produce partially purified recombinant beta 1gamma 2 dimers expressed in Sf9 cells using baculoviral vectors that showed quantitatively identical apparent rhodopsin affinity as homogenous preparations of the dimer.2 All beta gamma dimers utilized in the present study were purified by both DEAE-Sephacel and Ultrogel AcA44 chromatography with additional FPLC size-exclusion chromatography to assure hydrodynamic beta gamma dimers with defined detergent concentration, and they were assessed to contain no measurable contaminating GTP-binding proteins or pertussis toxin substrates. We also note that the beta 1gamma 211 dimer, which had equal apparent purity compared with the beta 1gamma 2 dimer sample, displayed reduced apparent affinity for rhodopsin, but not for Galpha t. Furthermore, although the measured affinity of the beta gamma dimers containing chimeric gamma  chains varied systematically with the carboxyl-terminal sequence of the gamma  chain, it did not vary systematically with sample purity, and the affinity of all samples for Galpha t was indistinguishable. We think it unlikely, then, that either specific contaminants or sample purity accounts for the differences in activities found in our recombinant beta gamma dimers.

Similar to the previously reported results from Sf9 expression systems (27, 31, 44), we found heterogeneity in isoprenoid modification of several of the Ggamma subunit constructs. There is no doubt that in the presence of a high concentration of virally encoded beta gamma substrate, both farnesyl- and geranylgeranyltransferases in Sf9 cells misprenylate a fraction of the gamma  protein. Whether such misprenylation is caused by excessive substrate, as suggested by Lindorfer et al. (31), or prenyltransferase specificity is also encoded by primary structures other than the CAAX motif, as suggested by Kalman et al. (44), remains to be tested. Neither our nor the previous data have directly assessed the prenyltransferase activities; rather, we have measured the long-term accumulation of recombinant protein products. Our data appear to suggest the lack of a consensus sequence upstream of the CAAX motif that directs farnesylation or geranylgeranylation since the proportion of prenylation did not vary systematically in our gamma 1/gamma 2 chimeras with the presence of gamma 1 or gamma 2 sequence. In addition to the lipid modification, Ggamma subunits are also methylated at the carboxyl-terminal cysteine after the proteolytic cleavage of the AAX tripeptide. The importance of the gamma  subunit carboxyl methylation to the beta gamma interaction with Galpha subunits has been reported (45, 46); its effect on beta gamma interaction with receptors has yet to be fully examined. Whatever the effect is, it should not complicate the interpretation of our data for the following reasons. First, our mass spectra showed that except for retinal beta 1gamma 1, which showed >50% methylation, all the Sf9-expressed beta 1gamma dimers were predominantly methylated (>90%). Second, we did not observe any difference among all the tested beta 1gamma dimers in their interaction with Galpha t, including retinal beta 1gamma 1. Moreover, fully methylated beta 1gamma 1 purified from heterologously expressed Sf9 cells showed low receptor coupling with adenosine receptors (28, 31), just as we have observed for retinal beta 1gamma 1 with rhodopsin.

The data presented in this study demonstrate that the prenyl group on t